Sumanta K. Pal: Eloquent discussion from Andrea Apolo National Cancer Institute synthesizing data from EV302 and CM901

Sumanta K. Pal, Co-Director of the City of Hope Kidney Cancer Program, posted on Twitter:

“Eloquent discussion from Andrea Apolo National Cancer Institute synthesizing data from EV302 and CM901. Loved the fact that she offered a strong, definitive opinion on the “winner” in the battle between these options. Also (not shown) great outline of remaining questions – what comes after EVP? “

Source: Sumanta K. Pal/Twitter